Exciting Advancement: Theradaptive’s Groundbreaking Pivotal Preclinical Study featured in Spine! We are thrilled to announce the publication of Theradaptive’s landmark study in Spine, the leading journal for the treatment of spinal disorders. This pivotal study showcases progression of fusion and healing time using an osteobiologic for interbody fusion in comparison to the standard of care in a large animal model. Our lead product for spinal fusion, OsteoAdapt SP, has been shown to enhance fusion and stimulate more robust bone formation at earlier time points in comparison to traditional iliac crest bone graft (ICBG). The study not only highlights OsteoAdapt’s performance but also demonstrates its effectiveness and safety in a clinically relevant animal model. Explore the full article below. Thanks to our amazing team for making this breakthrough possible! #SpinalFusion #BoneBiologics #MedicalResearch #Innovation #OrthopedicSurgery #BoneGraft #PreclinicalResearch
Sean LeSage
2mo
That’s a good start👍
Nick Benson
2mo
Congrats to Theradaptive and the authors!
Congratulations 🎉
Susan Porter
2mo
Congratulations Theradaptive Team
Nick Tressler
2mo
Congrats!
Chief Executive Officer at CMDC Labs
2moCongratulations to Theradaptive on the publication of your groundbreaking pivotal preclinical study in Spine! The promising results of OsteoAdapt SP in enhancing fusion and stimulating robust bone formation are truly impressive. Kudos to the entire team for this remarkable advancement in spinal fusion treatment! #SpinalFusion #BoneBiologics #MedicalResearch #Innovation